DOES «MAZE» PROCEDURE AFFECT ON HOSPITAL RESULTS OF MITRAL VALVE REPLACEMENT?
https://doi.org/10.35336/VA-2019-2-37-44
Abstract
Aims. To assess the outcomes of atrial fibrillation (AF) treatment by radiofrequency ablation for patients with mitral valve replacement, the analysis of short-term results of 128 patients was performed.
Methods. Mean age of the patients was 56,7±9,6 (29 - 79) years, males - 39, females - 89. Most of the patients had longstanding persistent AF - 81 (63,3%), 28 (21,9%) had persistent AF and 19 (14,8%) - paroxysmal AF. The indications for surgery were: rheumatic mitral valve disease in 105 patients (82%), degerative mitral valve disease - in 21 (16,4%) and with treated infectious endocarditis - in 2 (1,6%). Maze IV procedure was carried out in all cases.
Results. Hospital mortality was 0,8% (1 patient). Ten patients (7,9%) required pacemaker implantation. The indications were sinus node dysfunction in 7 patients, bradycardia AF - in 2 patients, AV node dysfunction - in 1. At the discharge 88 patients (69,3%) had a sinus rhythm, 10 (7,9%) - atrial rhythm, pacemaker rhythm with sinus node dysfunction patients - in 4 (3,1%) and AF - in 25 (19,7%). Thus, the rate of freedom from atrial fibrillation was 80,3% (102 patients). The effectiveness of ablation for paroxysmal AF was 100%, persistent - 74,1%, longstanding persistent - 77,8% (p=0,006). To reveal other predictors of freedom from AF at the discharge each ECHO parameter was included in the simple logistic regression analysis. Statistically significant p-value was obtained for the preoperative right atrial size (p=0,005), and close to it for the left atrial size, especially for the index left atrial volume/body surface area (p=0,052).
Conclusion. Thus, the radiofrequency ablation is an effective method for treatment of AF in patients undergoing mitral valve replacement. The rate of freedom from AF at the discharge is 80,3%. The predictors of freedom from AF at the discharge are preoperative form of AF and preoperative size of atria.
About the Authors
A. Sh. RevishviliRussian Federation
V. A. Popov
Russian Federation
V. V. Aminov
Russian Federation
M. A. Svetkin
Russian Federation
References
1. Gaynor S.L., Diodato M.D., Prasad S.M. et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. // J Thorac Cardiovasc Surg 2004;128:535-542.
2. Gillinov A.M., Gelijns A.C., Parides M.K. et al. Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery. // N Engl J Med 2015; 372:1399-1409.
3. Lee R., McCarthy P.M., Wang E.C. et al. Midterm survival in patients treated for atrial fibrillation: a propensity-matched comparison to patients without a history of atrial fibrillation. // J Thorac Cardiovasc Surg 2012;143:1341-51.
4. Bockeria L.A., Revishvili A.Sh., Muratov R.M. et al. Results of surgical treatment of chronic atrial fibrillation in patients with mitral valve disease. Europace. 2004;6:120.
5. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. Mar 1991;101(3):406 - 426.
6. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. Apr 1991;101(4):584-592.
7. Cox JL, Schuessler RB, D’Agostino HJ, Jr., et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. Apr 1991;101(4):569- 583.
8. Edgerton Z.J., Edgerton J.R. History of surgery for atrial fibrillation. // Heart Rhythm 2009;6:S1-S4.
9. Prasad S.M., Maniar H.S., Camillo C.J. et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. // J Thorac Cardiovasc Surg. Dec 2003;126(6):1822-1828.
10. Raanani E., Albage A., David T.E. et al. The efficacy of the Cox-maze procedure combined with mitral valve surgery: a matched control study. // Eur J Cardiothorac Surg. Apr 2001;19(4):438 - 442.
11. Phan K., Xie A., Tian D.H. et al. Systematic review and meta-analysis of surgical ablation for atrial fibrillation during mitral valve surgery. // Ann Cardiothorac Surg 2014;3(1):3-14.
12. La Meir M. Surgical options for treatment of atrial fibrillation. // Ann Cardiothorac Surg 2014;3(1):30-37.
13. Badhwar V., Rankin J.S., Damiano R.J., Jr. et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. // Ann Thorac Surg 2017;103:329-41.
14. Ревишвили А.Ш., Сергуладзе С.Ю., Кваша Б.И., Такаландзе Р.Г. и др. Ближайшие и отдаленные результаты хирургического лечения «изолированных» форм фибрилляции предсердий с помощью радиочастотной модификации операции «лабиринт-V» // Вестник аритмтлогии. 2016; 83:23-21.
15. Calkins H., Kuck K.H., Cappato R. et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and re- search trial design. // Europace 2012;14:528-606.
16. Damiano R.J., Jr., Schwartz F.H., Bailey M.S. et al. The Cox maze IV procedure: predictors of late recurrence. // J Thorac Cardiovasc Surg. Jan 2011;141(1):113-121.
17. Gillinov A.M., Bhavani S., Blackstone E.H. et al. Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. // Ann Thorac Surg. Aug 2006;82(2):502-513; discussion 513-504.
18. Gillinov A.M., Bakaeen F., McCarthy P.M. et al. Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation? // Ann Thorac Surg 2006;81:19-28.
19. Ad N., Henry L., Massimiano P. et al. The state of surgical ablation for atrial fibrillation in patients with mitral valve disease. // Curr Opin Cardiol 2013, 28:170-180.
20. Железнев С.И., Богачев-Прокофьев А.В., Пивкин А.Н и др. Лечение пароксизмальной фибрилляции предсердий при хирургии митрального клапана - нужно ли выполнять аблацию? // Анналы аритмологии. 2012; 1:66-71.
21. Богачев-Прокофьев А.В., Пивкин А.Н., Сырцева Я.В и др. Сочетанное лечение пароксизмальной фибрилляции предсердий у пациентов с пороками митрального клапана: анализ отдаленных результатов // Вестник аритмологии, 2017, №87, с. 16-22.
22. Ad N., Henry L., Hunt S., Holmes S.D. Impact of clinical presentation and surgeon experience on the decision to perform surgical ablation. // Ann Thorac Surg 2013;96:763-9.
23. An N., Holmes S.D. Prediction of sinus rhythm in patients undergoing concomitant Cox maze procedure through a median sternotomy. // J Thorac Cardiovasc Surg 2014;148:881-7.
24. An N., Holmes S.D., Shuman D.J., Pritchard G. Impact of atrial fibrillation duration on the success of firsttime concomitant Cox maze procedures. // Ann Thorac Surg 2015;100:1613-9
25. Dong L., Fu B., Teng X. et al. Clinical analysis of concomitant valve replacement and bipolar radiofrequency ablation in 191 patients. // J Thorac Cardiovasc Surg 2013;145:1013-7.
26. Lee J.W., Park N.H., Choo S.J. et al. Surgical outcome of the maze procedure for atrial fibrillation in mitral valve disease: rheumatic versus degenerative. // Ann Thorac Surg 2003;75:57-61.
Review
For citations:
Revishvili A.Sh., Popov V.A., Aminov V.V., Svetkin M.A. DOES «MAZE» PROCEDURE AFFECT ON HOSPITAL RESULTS OF MITRAL VALVE REPLACEMENT? Journal of Arrhythmology. 2019;26(2):37-44. (In Russ.) https://doi.org/10.35336/VA-2019-2-37-44